Department of Spine Surgery, China-Japan Union Hospital, Jilin University, No. 126, Xiantai Street, Changchun, 130033, Jilin Province, People's Republic of China.
Arthritis Res Ther. 2020 Apr 9;22(1):75. doi: 10.1186/s13075-020-2146-x.
Spinal cord ischemia-reperfusion injury (SCIRI) often leads to neurological damage and mortality. In this regard, understanding the pathology of SCIRI and preventing its development are of great clinic value.
Herein, we analyzed the role of bone marrow mesenchymal stem cell (BMMSC)-derived exosomal microRNA (miR)-124-3p in SCIRI. A SCIRI rat model was established, and the expression of Ern1 and M2 macrophage polarization markers (Arg1, Ym1, and Fizz) was determined using immunohistochemistry, immunofluorescence assay, RT-qPCR, and western blot analysis. Targeting relationship between miR-124-3p and Ern1 was predicted using bioinformatic analysis and verified by dual-luciferase reporter assay. Macrophages were co-cultured with miR-124-3p-containing BMMSC-derived exosomes. M2 macrophages were identified using flow cytometry, and the expression of Arg1, Ym1, and Fizz was determined. In addition, SCIRI rats were injected with miR-124-3p-containing exosomes, spinal cord cell apoptosis was observed using TUNEL assay, and the pathological condition was evaluated with H&E staining.
In SCIRI, Ern1 was highly expressed and M2 polarization markers were poorly expressed. Silencing Ern1 led to elevated expression of M2 polarization markers. MiR-124-3p targeted and negatively regulated Ern1. Exosomal miR-124-3p enhanced M2 polarization. Highly expressed exosomal miR-124-3p impeded cell apoptosis and attenuated SCIRI-induced tissue impairment and nerve injury. miR-124-3p from BMMSC-derived exosomes ameliorated SCIRI and its associated nerve injury through inhibiting Ern1 and promoting M2 polarization.
In summary, exosomal miR-124-3p derived from BMMSCs attenuated nerve injury induced by SCIRI by regulating Ern1 and M2 macrophage polarization.
脊髓缺血再灌注损伤(SCIRI)常导致神经损伤和死亡。在这方面,了解 SCIRI 的病理学并防止其发生具有重要的临床价值。
在此,我们分析了骨髓间充质干细胞(BMMSC)衍生的外泌体 microRNA(miR)-124-3p 在 SCIRI 中的作用。建立了 SCIRI 大鼠模型,通过免疫组织化学、免疫荧光分析、RT-qPCR 和 Western blot 分析测定 Ern1 和 M2 巨噬细胞极化标志物(Arg1、Ym1 和 Fizz)的表达。使用生物信息学分析预测 miR-124-3p 与 Ern1 的靶向关系,并通过双荧光素酶报告基因实验进行验证。将含有 miR-124-3p 的 BMMSC 衍生的外泌体与巨噬细胞共培养。使用流式细胞术鉴定 M2 巨噬细胞,并测定 Arg1、Ym1 和 Fizz 的表达。此外,向 miR-124-3p 含有外泌体的 SCIRI 大鼠注射,用 TUNEL 检测脊髓细胞凋亡,并通过 H&E 染色评估病理状况。
在 SCIRI 中, Ern1 表达上调,M2 极化标志物表达下调。沉默 Ern1 导致 M2 极化标志物表达上调。miR-124-3p 靶向并负调控 Ern1。外泌体 miR-124-3p 增强了 M2 极化。高表达的外泌体 miR-124-3p 阻碍细胞凋亡,减轻 SCIRI 引起的组织损伤和神经损伤。来自 BMMSC 衍生的外泌体的 miR-124-3p 通过抑制 Ern1 和促进 M2 巨噬细胞极化来改善 SCIRI 及其相关的神经损伤。
总之,BMMSC 衍生的外泌体 miR-124-3p 通过调节 Ern1 和 M2 巨噬细胞极化减轻 SCIRI 引起的神经损伤。